ctrl K

Watchlist Price Alert

CinCor Pharma Inc. (CINC)

NASDAQ: CINC · Real-Time Price · USD

29.06

0.00 (0.00%)

At close: Feb 23, 2023, 10:00 PM

CinCor Pharma Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020
Period Ending	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-82.53M	-67.98M	-51.8M	-42.51M	-22.79M	-15.1M	-9.93M	-5.51M
Interest Income	1.61M	344.51K	68.68K	21.64K	14.71K	12.77K	11.23K	6.81K
Pretax Income	-88.09M	-76.14M	-61.45M	-50.37M	-26.83M	-17.81M	-11.43M	-5.81M
Net Income	-93.31M	-82.62M	-68.49M	-54.47M	-26.83M	-17.81M	-11.43M	-5.81M
Selling & General & Admin	26.59M	25.11M	22.1M	18.99M	5.53M	2.49M	1.31M	390.17K
Research & Development	55.94M	42.87M	29.7M	23.52M	17.26M	12.61M	8.61M	5.12M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	82.53M	67.98M	51.8M	42.51M	22.79M	15.1M	9.93M	5.51M
Interest Expense	1.61M	344.51K	68.68K	21.64K	14.71K	12.77K	11.23K	6.81K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	82.53M	67.98M	51.8M	42.51M	22.79M	15.1M	9.93M	5.51M
Income Tax Expense	5.22M	6.48M	7.04M	4.1M	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	40.81M	37.71M	33.43M	35.42M	35.42M	34.36M	34.36M	36.52M
Shares Outstanding (Diluted)	40.81M	37.71M	33.43M	35.42M	35.42M	34.36M	34.36M	36.52M
EPS (Basic)	-2.55	-2.32	-1.97	-1.54	-0.76	-0.51	-0.32	-0.16
EPS (Diluted)	-2.55	-2.32	-1.97	-1.54	-0.76	-0.51	-0.32	-0.16
EBITDA	-86.63M	-73.41M	-58.44M	-50.35M	-26.82M	-17.8M	-11.42M	-5.8M
EBIT	-86.48M	-75.8M	-61.38M	-50.35M	-26.82M	-17.8M	-11.42M	-5.8M
Depreciation & Amortization	-963.03K	-2.3M	-3.59M	-7.84M	-4.03M	-2.7M	-1.49M	-288.81K